| Literature DB >> 33302594 |
Deyana D Lewis1, Cheryl D Cropp2.
Abstract
Prostate cancer disproportionately affects men of African ancestry at nearly twice the rate of men of European ancestry despite the advancement of treatment strategies and prevention. In this review, we discuss the underlying causes of these disparities including genetics, environmental/behavioral, and social determinants of health while highlighting the implications and challenges that contribute to the stark underrepresentation of men of African ancestry in clinical trials and genetic research studies. Reducing prostate cancer disparities through the development of personalized medicine approaches based on genetics will require a holistic understanding of the complex interplay of non-genetic factors that disproportionately exacerbate the observed disparity between men of African and European ancestries.Entities:
Keywords: African ancestry; clinical trials; genetics; health disparity; prostate cancer
Year: 2020 PMID: 33302594 PMCID: PMC7762993 DOI: 10.3390/genes11121471
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096